Sir, Central corneal haze after wedge resection following penetrating keratoplasty and photorefractive keratectomy Arcuate keratotomy is a common procedure after keratoplasty, but can induce central corneal haze in eyes with a history of PRK. Herein, we report on a patient with the history of uncomplicated penetrating corneal transplantation with uncomplicated PRK, who developed central corneal haze 6 months after wedge resection. 1 
Case report
A 34-year-old man with keratotconus underwent penetrating keratoplasty in the right eye in 1993 and arcuate keratotomies (AK) for high astigmatism in 2000. A PRK for a refraction of À 1.0 Â À 2.0/1401 without mitomycine C (MMC) was done in 2005.
Postoperative course was uncomplicated including a clear cornea and uncorrected distance visual acuity (UDVA) was 0.2 logMAR 6 months after PRK. The patient's vision decreased 5 years later again due to inferior corneal steepening and wedge resection (two opposite 601 AK in the 6.0-mm central optical zone with six compression sutures using 10-0 nylon) was performed to treat irregular astigmatism. 
Correspondence
The cornea developed severe central haze with decrease of vision to 2.0 logMAR with a refraction of À 1.0E À 2.5/180 6 months later ( Figure 1a ). MMC 0.02% was applied therefore as a therapeutic option for 45 s on a sponge after epithelial removal. 2 Haze disappeared 4 months later and UDVA increased to 0.2 logMAR. The cornea remained clear for the follow-up period of 21 months (Figure 1b ).
Comments
Haze formation is possible in the central cornea after incisional surgery in eyes with a history of PRK, even if the cornea was clear.
However, lamellar transplantation has been described as therapeutic option for visual recovery in such cases, 3 but this case shows that a single topical application of MMC 0.02% for 45 s is a suitable treatment option and the cornea remained clear for the entire postoperative follow-up period of 21 months.
Incisional surgery is a risk factor for eyes with a history of PRK, but MMC 0.02% application is a useful therapeutic option for the removal of corneal haze.
Sir, Intra-lesional interferon injection for recurrent conjunctival MALT lymphoma
Conjunctival mucosa-associated lymphoid tissue (MALT) lymphomas are localized low-grade extra-nodal tumours that are managed with radiotherapy, cryotherapy, surgical excision, or even observation.
Intra-lesional interferon injection for conjunctival lymphomas was first cited as early as 1996 by Cellini et al; 1 its successful use has been reported since then. 2, 3 We report a case where its use has been invaluable in a patient with recurrent conjunctival MALT lymphoma following external beam radiation.
Case report
A 55-year-old woman presented with a 2-week history of red watery right eye and swelling of her right lower lid. On examination, she had a salmon pink mass in the right inferior bulbar conjunctiva (Figure 1a) . The rest of the ocular examination was normal. Conjunctival biopsy confirmed this to be an extra-nodal marginal-zone MALTtype lymphoma. The patient was treated with external beam radiation (24 Gy in 12 fractions) to the right inferior conjunctiva with complete regression of the lymphoma.
At 10 months post radiotherapy, she was noted to have a similar pink lesion in the right superior bulbar conjunctiva (Figure 1b) . A biopsy confirmed recurrent MALT lymphoma (Figure 1c) .
Owing to recent external beam radiotherapy it was felt inappropriate to re-treat her with the same modality and she was treated with intra-lesional interferon injection.
She received a 4-week course of 3 times a week intralesional injections of 1.5 mega-units in 0.25 ml of Interferon a2A, with complete regression of the lesion.
She remains disease free at 10 months follow-up. 
